An fMRI Study on Temporal Discounting in Bipolar Disorder
Reconceptualizing Suicide as Impaired Temporal Discounting: an fMRI Study in Bipolar Disorder
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02144
- Bipolar Clinic and Research Program at Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Meets DSM-IV criteria for BD I and II current depressive episode
- Able to give written informed consent
- Age > to 18 years and < 65 years
- Currently suicidal as defined by a MADRS suicide item score of > 3 or previous history of serious suicidal ideation that required hospitalization.
- All subjects need to have normal hearing and normal/corrected-to-normal vision.
Exclusion Criteria:
- Medical illness or non-psychiatric medical treatment that would likely interfere with study participation
- Neurologic disorder, previous ECT, or history of head trauma (i.e. known structural brain lesion potentially confounding MRI results)
- Substance abuse within the past 3 months or current substance dependence (confirmed by MINI)
- Left-handedness
- Contraindications to MRI (metallic implants, claustrophobia, etc.)
- Subjects who need urgent psychiatric care requiring hospitalization (evaluated by clinicians).
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Bipolar I or II Disorder
30 currently depressed patients with DSM-IV bipolar I and II disorder who are currently or previously suicidal will receive fMRI.
|
Imaging will be performed on a 3T Siemens Trio scanner.
Each MRI scanning session will last no more than 90 minutes.
fMRI will be used to determine brain activation and differences in intertemporal discounting.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Magnetic Resonance Imaging (fMRI) to examine brain activation and differences in intertemporal discounting
Time Frame: Participants will be analyzed as quickly as possible after a screening visit, an expected average of 2 weeks
|
Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of intertemporal discounting in patients with bipolar I and II disorder
|
Participants will be analyzed as quickly as possible after a screening visit, an expected average of 2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2013P000003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.